Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.46 USD
+0.06 (4.29%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $1.48 +0.02 (1.37%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Pacific Biosciences of California (PACB) reported earnings of -$0.27 per share, beating the Zacks Consensus Estimate of $-0.31 per share. This reflects a positive earnings surprise of 12.90%. Look out for PACB's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 16.13%.
Earnings History
Price & Consensus
Zacks News for PACB
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services